Effects of acute and chronic valproate treatments on p-CREB levels in the rat amygdala and nucleus accumbens

Brain Research

Volumn 1141, Issue 1, 2007, Pages 15-24

  Casu, Maria Antonietta ^a   Sanna, Angela ^a   Spada, Gabriele Pinna ^a   Falzoi, Matteo ^a   Mongeau, Raymond ^a   Pani, Luca ^a,b  

^a Neuroscienze PharmaNess Scarl   (Italy)

^b Sezione di Cagliari   (Italy)

Author keywords

Amygdala; Immunohistochemistry; Mania; Mood disorders; Nucleus accumbens; p CREB; Valproate; Western blot

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MOOD STABILIZER; VALPROIC ACID;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN CORTEX; BRAIN REGION; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; STEREOMETRY; THERAPY EFFECT; TREATMENT DURATION; WESTERN BLOTTING;

AMYGDALA; ANIMALS; BLOTTING, WESTERN; CELL COUNT; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VALPROIC ACID;

RATTUS;

EID: 33947148748     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.01.004     Document Type: Article

References (37)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lindgren K.A., Holden J.E., Perlman S.B., Turski P.A., Krahn D.D., Benca R.M., and Davidson R.J. Metabolic rate in the right amygdala predicts negative affect in depressed patients. NeuroReport 9 (1998) 3301-3307
2. Altshuler L., Bookheimer S., Proenza M.A., Townsend J., Sabb F., Firestine A., Bartzokis G., Mintz J., Mazziotta J., and Cohen M.S. Increased amygdala activation during mania: a functional magnetic resonance imaging study. Am. J. Psychiatry 162 (2005) 1211-1213
3. Barrot M., Olivier J.D., Perrotti L.I., DiLeone R.J., Berton O., Eisch A.J., Impey S., Storm D.R., Neve R.L., Yin J.C., Zachariou V., and Nestler E.J. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 11435-11440
4. Barrot M., Wallace D.L., Bolanos C.A., Graham D.L., Perrotti L.I., Neve R.L., Chambliss H., Yin J.C., and Nestler E.J. Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8357-8362
5. Baumann B., Danos P., Krell D., Diekmann S., Leschinger A., Stauch R., Wurthmann C., Bernstein H.G., and Bogerts B. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J. Neuropsychiatry Clin. Neurosci. 11 (1999) 71-78
6. Bezchlibnyk Y., and Young L.T. The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression. Can. J. Psychiatry 47 (2002) 135-148
7. Bito H., and Takemoto-Kimura S. Ca(2+)/CREB/CBP-dependent gene regulation: a shared mechanism critical in long-term synaptic plasticity and neuronal survival. Cell Calcium 34 (2003) 425-430
8. Bowley M.P., Drevets W.C., Ongur D., and Price J.L. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry 52 (2002) 404-412
9. Carlezon Jr. W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
10. Casu M.A., Dinucci D., Colombo G., Gessa G.L., and Pani L. Reduced DAT- and DBH-immunostaining in the limbic system of Sardinian alcohol-preferring rats. Brain Res. 948 (2002) 192-202
11. Corbett R., Fielding S., Cornfeldt M., and Dunn R.W. GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Psychopharmacology (Berlin) 104 (1991) 312-316
12. Dalvi A., and Rodgers R.J. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berlin) 128 (1996) 380-397
13. Drevets W.C., Bogers W., and Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur. Neuropsychopharmacol. 12 (2002) 527-544
14. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23 (2003) 7311-7316
15. Freeman M.P., Freeman S.A., and McElroy S.L. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J. Affect. Disord. 68 (2002) 1-23
16. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., and Pakkenberg B. The new stereological tools: dissector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96 (1988) 857-881
17. Herdegen T., and Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28 (1998) 370-490
18. Kelley A.E. Functional specificity of ventral striatal compartments in appetitive behaviors. Ann. N. Y. Acad. Sci. 877 (1999) 71-90
19. Ketter T.A., Kimbrell T.A., George M.S., Dunn R.T., Speer A.M., Benson B.E., Willis M.W., Danielson A., Frye M.A., Herscovitch P., and Post R.M. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol. Psychiatry 49 (2001) 97-109
20. Lum M., Fontaine R., Elie R., and Ontiveros A. Probable interaction of sodium divalproex with benzodiazepines. Prog. Neuropsychopharmacol. Biol. Psychiatry 15 (1991) 269-273
21. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
22. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev., Mol. Cell Biol. 2 (2001) 599-609
23. McClung C.A., and Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci. 6 (2003) 1208-1215
24. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
25. Newton S.S., Thome J., Wallace T.L., Shirayama Y., Schlesinger L., Sakai N., Chen J., Neve R., Nestler E.J., and Duman R.S. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22 (2002) 10883-10890
26. Paxinos, G. and Watson, C., 1998. The Rat Brain in stereotaxic coordinates.
27. Petty F., Davis L.L., Nugent A.L., Kramer G.L., Teten A., Schmitt A., and Stone R.C. Valproate therapy for chronic, combat-induced posttraumatic stress disorder. J. Clin. Psychopharmacol. 22 (2002) 100-101
28. Pi X., Lee J., Li F., and Rosenberg H.C. Decreased expression of brain cAMP response element-binding protein gene following pentylenetetrazol seizure. Brain Res. Mol. Brain Res. 127 (2004) 60-67
29. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., and Carlezon Jr. W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21 (2001) 7397-7403
30. Rubino T., Forlani G., Vigano D., Zippel R., and Parolaro D. Modulation of extracellular signal-regulated kinases cascade by chronic delta 9-tetrahydrocannabinol treatment. Mol. Cell. Neurosci. 25 (2004) 355-362
31. Sheline Y.I., Barch D.M., Donnelly J.M., Ollinger J.M., Snyder A.Z., and Mintun M.A. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50 (2001) 651-658
32. Siegle G.J., Steinhauer S.R., Thase M.E., Stenger V.A., and Carter C.S. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 51 (2002) 693-707
33. Soderling T.R. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 24 (1999) 232-236
34. Swanson L.W., and Petrovich G.D. What is the amygdala?. Trends Neurosci. 21 (1998) 323-331
35. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., and Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20 (2000) 4030-4036
36. Wallace T.L., Stellitano K.E., Neve R.L., and Duman R.S. Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biol. Psychiatry 56 (2004) 151-160
37. Young L.T., Bezchlibnyk Y.B., Chen B., Wang J.F., and MacQueen G.M. Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol. Psychiatry 55 (2004) 570-577